Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 10.31%813M | -3.14%895M | -4.15%1.53B | -9.03%3.93B | -31.27%677M | 80.64%737M | -37.99%924M | 10.79%1.59B | 82.43%4.32B | 52.24%985M |
| Net income from continuing operations | -87.03%264M | -54.63%186M | -25.93%-102M | -24.43%1.72B | -450.00%-644M | 62.80%2.04B | -51.07%410M | -2,125.00%-81M | 233.88%2.28B | 9.52%184M |
| Operating gains losses | -206.57%-146M | 298.00%199M | -66.07%19M | 510.88%1.17B | 943.64%928M | 302.94%137M | 142.37%50M | 205.66%56M | -138.31%-285M | 60.85%-110M |
| Depreciation and amortization | 12.25%504M | 9.60%491M | 11.99%495M | 5.64%1.8B | 4.07%460M | 8.19%449M | 7.18%448M | 3.27%442M | 3.84%1.7B | 7.02%442M |
| Remuneration paid in stock | -104.84%-3M | -32.79%41M | 37.78%62M | 242.86%192M | -7.69%24M | 12.73%62M | 188.41%61M | 2.27%45M | -49.55%56M | -35.00%26M |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 71.05%-11M | ---- | ---- |
| Deferred tax | 121.16%245M | -1,280.00%-69M | -809.09%-78M | -2,527.66%-1.24B | -45.61%-83M | -1,686.30%-1.16B | 85.29%-5M | 137.93%11M | -136.43%-47M | -111.11%-57M |
| Other non cashItems | 50.00%-7M | 22.22%33M | -236.36%-37M | 173.40%69M | 391.30%67M | 72.55%-14M | 1,000.00%27M | 35.29%-11M | -62.07%-94M | 8.00%-23M |
| Change In working capital | 94.32%-44M | 120.90%14M | 3.27%1.17B | -69.90%214M | -114.34%-75M | 43.42%-774M | -114.63%-67M | 2.91%1.13B | -52.54%711M | 47.32%523M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 10.31%813M | -3.14%895M | -4.15%1.53B | -9.03%3.93B | -31.27%677M | 80.64%737M | -37.99%924M | 10.79%1.59B | 82.43%4.32B | 52.24%985M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 171.43%100M | 162.60%241M | -2,057.14%-137M | 25.40%-1.36B | -192.39%-845M | -97.18%-140M | 46.38%-385M | 100.93%7M | 26.86%-1.83B | -310.95%-289M |
| Net PPE purchase and sale | -32.31%-602M | -50.53%-712M | -29.66%-695M | -68.54%-2.64B | -270.89%-1.17B | -66.67%-455M | 9.90%-473M | -19.11%-536M | 0.51%-1.56B | 3.36%-316M |
| Net investment purchase and sale | 111.50%662M | 881.44%952M | -0.92%538M | 620.00%1.27B | 744.74%321M | 51.94%313M | 150.26%97M | 283.45%543M | 74.45%-245M | -91.26%38M |
| Net other investing changes | 1,900.00%40M | 111.11%1M | --20M | 94.44%-1M | 154.55%6M | 150.00%2M | ---9M | ---- | -154.55%-18M | -137.93%-11M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 171.43%100M | 162.60%241M | -2,057.14%-137M | 25.40%-1.36B | -192.39%-845M | -97.18%-140M | 46.38%-385M | 100.93%7M | 26.86%-1.83B | -310.95%-289M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -64.52%-357M | -388.09%-1.15B | 67.10%-561M | -21.28%-2.87B | -115.36%-715M | 73.18%-217M | 74.87%-235M | -483.90%-1.71B | -46.90%-2.37B | 55.07%-332M |
| Net issuance payments of debt | -64.98%-358M | -176.50%-647M | 86.03%-234M | 0.08%-2.37B | 27.71%-240M | 73.14%-217M | 74.97%-234M | -471.67%-1.68B | -46.90%-2.37B | 55.14%-332M |
| Net common stock issuance | --1M | ---500M | ---327M | -47,300.00%-472M | ---472M | --0 | --0 | --0 | -83.33%1M | --0 |
| Net other financing activities | ---- | ---- | ---- | -3,300.00%-34M | ---3M | ---- | ---1M | ---30M | 83.33%-1M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -64.52%-357M | -388.09%-1.15B | 67.10%-561M | -21.28%-2.87B | -115.36%-715M | 73.18%-217M | 74.87%-235M | -483.90%-1.71B | -46.90%-2.37B | 55.07%-332M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.43%3.34B | 23.75%3.36B | -10.61%2.52B | 4.60%2.82B | 37.93%3.39B | 3.25%3.02B | -12.10%2.72B | 4.60%2.82B | -39.00%2.69B | -7.03%2.46B |
| Current changes in cash | 46.32%556M | -103.62%-11M | 881.13%828M | -344.00%-305M | -342.58%-883M | 180.51%380M | 286.50%304M | -126.77%-106M | 107.18%125M | 708.89%364M |
| Effect of exchange rate changes | 75.00%-2M | -1,500.00%-14M | 200.00%15M | 700.00%6M | 214.29%8M | -233.33%-8M | 200.00%1M | 400.00%5M | -105.00%-1M | -450.00%-7M |
| End cash Position | 14.65%3.89B | 10.43%3.34B | 23.75%3.36B | -10.61%2.52B | -10.61%2.52B | 37.93%3.39B | 3.25%3.02B | -12.10%2.72B | 4.60%2.82B | 4.60%2.82B |
| Free cash from | -25.18%211M | -59.42%183M | -21.31%831M | -53.05%1.29B | -173.99%-495M | 108.89%282M | -53.26%451M | 6.99%1.06B | 246.23%2.76B | 109.06%669M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.